SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of
the WpHG (the German Securities Trading Act) with the objective of Europe-wide
distribution
EQS Voting Rights Announcement: SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA: Release according to Article 40, Section 1 of
the WpHG (the German Securities Trading Act) with the objective of
Europe-wide distribution
24.06.2024 / 17:00 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Notification of Major Holdings
1. Details of issuer
Name: SCHOTT Pharma AG & Co. KGaA
Street: Hattenbergstraße 10
Postal code: 55122
City: Mainz
Germany
Legal Entity Identifier (LEI): 529900TU48UE99NHEY88
2. Reason for notification
X Acquisition/disposal of shares with voting rights
X Acquisition/disposal of instruments
Change of breakdown of voting rights
Other reason:
3. Details of person subject to the notification obligation
Legal entity: The Capital Group Companies, Inc.
City of registered office, country: Los Angeles, United States of
America (USA)
4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
SMALLCAP World Fund, Inc.
5. Date on which threshold was crossed or reached:
20 Jun 2024
6. Total positions
% of voting % of voting rights Total of Total number of
rights attached through both in % voting rights
to shares instruments (total (7.a. + pursuant to
(total of 7.a.) of 7.b.1 + 7.b.2) 7.b.) Sec. 41 WpHG
New 3.01 % 0.29 % 3.31 % 150614616
Previo- 2.96 % 0.34 % 3.30 % /
us
notifi-
cation
7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN Absolute In %
Direct (Sec. Indirect (Sec. Direct (Sec. Indirect
33 WpHG) 34 WpHG) 33 WpHG) (Sec. 34
WpHG)
DE000A3ENQ51 0 4539746 0 % 3.01 %
Total 4539746 3.01 %
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of Expiration or Exercise or Voting Voting
instrument maturity date conversion rights rights in
period absolute %
0 0 %
Total 0 0.00 %
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of Expiration Exercise or Cash or Voting Voting
instrument or conversion physical rights rights
maturity period settlement absolute in %
date
Rights to recall Physical 442088 0.29 %
lent shares of settlement
Common Stock
Total 442088 0.29 %
8. Information in relation to the person subject to the notification
obligation
Person subject to the notification obligation is not controlled nor
does it control any other undertaking(s) that directly or
indirectly hold(s) an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate
controlling natural person or legal entity:
Name % of voting % of voting rights Total of both
rights (if at through instruments (if (if at least
least 3% or at least 5% or more) 5% or more)
more)
The Capital % % %
Group
Companies,
Inc.
Capital 3.01 % % %
Research and
Management
Company
- % % %
9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34
para. 1 sent. 1 No. 6 WpHG)
Date of general meeting:
Holding total positions after general meeting (6.) after annual general
meeting:
Proportion of voting Proportion of Total of
rights instruments both
% % %
10. Other explanatory remarks:
Date
21 Jun 2024
---------------------------------------------------------------------------
24.06.2024 CET/CEST The EQS Distribution Services include Regulatory
Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
---------------------------------------------------------------------------
Language: English
Company: SCHOTT Pharma AG & Co. KGaA
Hattenbergstraße 10
55122 Mainz
Germany
End of News EQS News Service
---------------------------------------------------------------------------
1931927 24.06.2024 CET/CEST